Santhera, Maker of Mitochondrial Eye Disease Therapy Raxone, Joining Key Foundation Council
Santhera Pharmaceuticals, developer of the mitochondrial eye disease therapy Raxone, is taking a seat on the United Mitochondrial Disease Foundation industry advisory council. Dr. Jodi Wolff, who is known for her expertise on the disease and her patient advocacy work, will represent Santhera on the council. She is the company’s director…